在人类细胞中使用菌体抗CRISPR蛋白质降解Cas9
Zuriah Meacham1, Luisa Arake de Tacca1, Joseph Bondy-Denomy2
1Acrigen Biosciences, Inc., Alameda, California, United States of America.
PLoS biology
|December 8, 2023
概括
在人类细胞中,像AcrIIA1这样的抗CRISPR (Acr) 蛋白质会降解CRISPR-Cas核酶,如Cas9. 这一发现为精确的基因编辑疗法提供了新的工具.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 微生物学 微生物学
背景情况:
- 菌体利用抗CRISPR (Acr) 蛋白质使细菌的CRISPR-Cas免疫系统无法成功复制.
- 在ACR蛋白中,使用多种机制来抑制CRISPR-Cas系统.
- 已知Streptococcus pyogenes Cas9 (SpyCas9) 抑制剂AcrIIA1被各种菌体和等离子体编码.
研究的目的:
- 为了研究人类细胞中CRISPR-Cas系统AcrIIA1抑制的机制.
- 为了确定AcrIIA1是否可以诱导Cas9核酶的降解.
- 探索AcrIIA1介导的Cas9降解的治疗潜力.
主要方法:
- 进行了人类细胞培养实验,观察AcrIIA1与SpyCas9和金黄色葡萄球菌Cas9 (SauCas9) 的相互作用.
- 用AcrIIA1的变异来确定负责Cas9降解的关键相互作用域.
- 在存在 AcrIIA1.1 的情况下,评估了 CRISPR-Cas9 核酶活性.
主要成果:
- 观察到AcrIIA1诱导人体细胞中SpyCas9和SauCas9的降解,这是Acr蛋白的新发现.
- 突变破坏了AcrIIA1和Cas9之间的物理相互作用,取消了降解效应.
- 这表明,Cas9降解的机制取决于直接的蛋白质与蛋白质相互作用.
结论:
- 通过直接相互作用,AcrIIA1在人类细胞中积极降解Cas9核酶.
- 由AcrIIA1对Cas9的有针对性的降解为调节基因编辑活动提供了一种新的策略.
- AcrIIA1的特性可以使CRISPR-Cas蛋白解向仿真体 (PROTACs) 的发展成为更安全的基因编辑应用.
更多相关视频
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
7.9K
11:35Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
12.6K
相关概念视频
CRISPR
51.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.6K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
